Skip to main content
. 2011 Aug;32(7):1195–1201. doi: 10.3174/ajnr.A2501

Table 3:

Tumor perfusion parameters by LRC status, before, during, and after RTa

Parameter Locoregional Status Baseline Prior to RT, LRF (n = 2); LRC (n = 13) During RT (SD)
6 Weeks Post-RT, LRF (n = 2); LRC (n = 10)
Week 2, LRF (n = 2); LRC (n = 13) Week 4, LRF (n = 2); LRC (n = 12) Week 6, LRF (n = 1); LRC (n = 10)
BF (mL/100 g/min) LRF 53.4 (1.8) 43.9 (9.9) 217.7 (243.8) 16.2 (NA) 28.4 (20.8)
LRC 118.0 (66.1) 135.8 (71.5) 91.6 (51.9) 137.8 (149.0) 71.5 (56.6)
P value .004 .0008 .598 NA .122
BV (ml/100 g) LRF 4.5 (1.9) 3.6 (1.1) 6.7 (6.2) 2.3 (NA) 3.2 (3.1)
LRC 5.6 (2.0) 6.1 (2.5) 4.6 (2.2) 6.2 (4.9) 4.0 (2.8)
P value .546 .081 .721 NA .766
MTT (s) LRF 6.4 (2.0) 7.2 (2.8) 3.5 (1.8) 11.1 (NA) 7.8 (2.2)
LRC 4.9 (2.6) 4.4 (2.2) 5.1 (4.7) 4.2 (1.3) 5.7 (2.5)
P value .461 .379 .438 NA .381
CP (mL/100 g/min) LRF 7.7 (2.3) 6.6 (5.6) 29.5 (28.5) 4.4 (NA) 9.9 (9.2)
LRC 16.6 (9.3) 22.0 (7.5) 19.0 (11.1) 11.3 (8.1) 15.6 (8.9)
P value .02 .098 .694 NA .537
a

Data are presented as a mean ± SD. P values are calculated from an independent samples t test comparing mean CTP parameter values in the LRC versus LRF groups. CTP parameters were not measured at week 6 in 1 of the 2 patients with LRF; these are indicated by NA.